Decision-making algorithm for ascending aortic aneurysm: Effectiveness in clinical application?


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
05 2019
Historique:
received: 17 04 2018
revised: 21 08 2018
accepted: 04 09 2018
pubmed: 24 12 2018
medline: 25 2 2020
entrez: 24 12 2018
Statut: ppublish

Résumé

The risk of rupture and dissection in ascending thoracic aortic aneurysms increases as the aortic diameter exceeds 5 cm. This study evaluates the clinical effectiveness of a specific algorithm based on size and symptoms for preemptive surgery to prevent complications. A total of 781 patients with nondissecting ascending thoracic aortic aneurysms who presented electively for evaluation to our institution from 2011 to 2017 were triaged to surgery (n = 607, 77%) or medical observation (n = 181, 24%) based on a specific algorithm: surgery for large (>5 cm) or symptomatic aneurysms. A total of 309 of 781 patients did not undergo surgery. Of these, 128 (16%) had been triaged to prompt repair but did not undergo surgery for a variety of reasons ("surgery noncompliant and overwhelming comorbidities" group). Another 181 patients (24%) were triaged to medical management ("medical" group). In the "surgery noncompliant and overwhelming comorbidities" versus the "medical" group, mean aortic diameters were 5 ± 0.5 cm versus 4.45 ± 0.4 cm and aortic events (rupture/dissection) occurred in 17 patients (13.3%) versus 3 patients (1.7%), respectively (P < .001). Later elective surgeries (representing late compliance in the "surgery noncompliant and overwhelming comorbidities group" or onset of growth or symptoms in the "medical" group) were conducted in 21 patients (16.4%) versus 15 patients (8.3%) (P = .04), respectively. Death ensued in 20 patients (15.6%) versus 6 patients (3.3%) (P < .001), respectively. In the "surgery noncompliant and overwhelming comorbidities" group, 7 of 20 patients died of definite aortic causes compared with none in the "medical" group. Patients with ascending thoracic aortic aneurysms who did not follow surgical recommendations experienced substantially worse outcomes compared with medically triaged candidates. The specific algorithm based on size and symptoms functioned effectively in the clinical setting, correctly identifying both at-risk and safe patients.

Identifiants

pubmed: 30579535
pii: S0022-5223(18)32927-1
doi: 10.1016/j.jtcvs.2018.09.124
pii:
doi:

Types de publication

Journal Article Webcast

Langues

eng

Sous-ensembles de citation

IM

Pagination

1733-1745

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Ayman Saeyeldin (A)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Internal Medicine, Saint Mary's Hospital, Waterbury, Conn.

Mohammad A Zafar (MA)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Yupeng Li (Y)

Department of Political Sciences and Economics, Rowan University, Glassboro, NJ.

Maryam Tanweer (M)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Mohamed Abdelbaky (M)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Anton Gryaznov (A)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Surgery, Saint Mary's Hospital, Waterbury, Conn.

Adam J Brownstein (AJ)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Camilo A Velasquez (CA)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Joelle Buntin (J)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Kabir Thombre (K)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn.

Wei-Guo Ma (WG)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Cardiovascular Surgery, Beijing Anzhen Hospital of Capital Medical University, Beijing, China.

Young Erben (Y)

Department of Vascular Surgery, Yale University School of Medicine, New Haven, Conn.

John A Rizzo (JA)

Department of Economics and Department of Preventive Medicine, Stony Brook University, Stony Brook, NY.

Bulat A Ziganshin (BA)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn; Department of Surgical Diseases #2, Kazan State Medical University, Kazan, Russia.

John A Elefteriades (JA)

Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Conn. Electronic address: john.elefteriades@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH